Recent Finacing
Recent Raise
AGI Biopharmaceuticals is a European biotech developing a patented melanoma vaccine (molecular key matching about 30% of cases), tested in six human trials since 1995 and pursuing multi‑cancer applications.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor